Navigation Links
Research explores lung cancer among pediatric cancer patients

Because primary lung adenocarcinoma is exceedingly rare in the pediatric population, it is difficult to properly classify certain lung tumors in children and adolescents. While anecdotal reports of pediatric patients with lung cancer lesions exist, little research has been conducted to link the disease in children to similar pulmonary malignancies in adults. Through an assessment of clinical, tissue-based and molecular data for pediatric lung cancer, research published in the November edition of the Journal of Thoracic Oncology determined that pulmonary lesions found in young patients with pediatric cancers can be histologically indistinguishable from lung adenocarcinoma seen in adults. Findings indicate that lung adenocarcinomas could occur prior to chemotherapy treatment for a second cancer, and some tumors display gene mutations in EGFR and KRAS this is the first documentation of these mutations in pediatric adenocarcinoma.

Until now, it had seemed reasonable to consider these rare pulmonary tumors as secondary malignancies in children, caused by treatment for other cancers. In this newly published study (the largest study of its kind), however, the tumors of eight patients between the age of 10 and 24 years, all never smokers, were evaluated in terms of histopathologic and molecular data.

Researchers determined that these tumors are (1) adenocarcinomas ranging from bronchioloalveolar carcinoma (BAC), or adenocarcinoma in situ (AIS), to invasive histologic patterns and (2) may be present before administration of chemotherapy for the underlying malignancy, and therefore are not always or necessarily secondary malignancies, as had been previously believed. This study clearly documents the invasive patterns of lung cancer in pediatric cancer patients and suggests that the simultaneous presence of a primary malignancy and pulmonary adenocarcinoma may reflect more than coincidence.

"In the past, because of the unusually young age, we were reluctant to call such tumors 'BAC' and instead qualified these cases as 'BAC-like nodule,'" explained lead investigator, Dr. Marc Ladanyi of Memorial Sloan-Kettering Cancer Center. "Our findings now confirm the presence of EGFR and KRAS mutations in some of these pediatric lung cancers in a proportion similar to lung cancers seen in adults, which allows us to more confidently propose that this is genuine lung cancer in the pediatric population. The clinical course of these lung adenocarcinomas in children remains unclear because all 8 patients had their lung tumors fully removed without subsequent recurrence. This may reflect the fact that half of the patients had AIS, which is now recognized to have a 100 percent disease free survival for completely resected cases. An open question is whether these lung adenocarcinomas are increasing in the pediatric age group or is this due to a detection bias due to more detailed lung imaging in patients with common, non-pulmonary, childhood cancers."


Contact: Kaitlin Doody
International Association for the Study of Lung Cancer

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award
Post Your Comments:
(Date:11/27/2015)... , ... November 27, 2015 , ... A team of ... ways to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy ...
(Date:11/27/2015)... ... 27, 2015 , ... ProSidebar: Fashion is a set of 30 ... ProSidebar: Fasion, video editors can easily add an informative sidebar to any FCPX production. ... Utilize presets featuring self-animating drop zones, lines, bars, and text with the ease of ...
(Date:11/27/2015)... ... 27, 2015 , ... The moment you stop improving is ... fulfilling the needs of advisers and clients but going above and beyond to ... customer service. However, there's always room for improvement, which is why the entire ...
(Date:11/27/2015)... ... 2015 , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his ... is one of Joplin's most famous and beautiful concert posters. The concert was held ... Ann Arbor. The According to Hawley, "It is hard to believe that Joplin's stardom ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... Travel Representative. As a franchise owner, Somu now offers travelers, value and care ... wedding packages, private cruise sales, as well as, cabin upgrades and special amenities ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 Research and ... "Asia Pacific Cardiac Pacemaker Market Outlook to 2019 - ... Drive the Demand " report to their offering. ... --> Boston scientific and others. ... global players including Medtronic, Biotronik, Boston ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
(Date:11/26/2015)... , November 26, 2015 ... Juntendo universitetssjukhus ser potential att använda ... magnetresonansbilder (MR-bilder) för patienter med multipel ... ett forskningsavtal med SyntheticMR AB för att ... forskningsprojekt på sjukhuset. Med SyMRI kan man ...
Breaking Medicine Technology: